Liu David R. 4
4 · Prime Medicine, Inc. · Filed Jun 16, 2025
Insider Transaction Report
Form 4
Liu David R.
10% Owner
Transactions
- Purchase
Common Stock
2025-06-16$1.49/sh+21,000$31,196→ 20,198,945 total
Footnotes (2)
- [F1]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025.
- [F2]The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.46 to $1.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.